Top Markets
Coin of the day
Adynxx, Inc. Adynxx, Inc.

Adynxx, Inc.

ADYX
Rank in Stocks #42632
Adynxx, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating... Adynxx, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating and commercializing novel transcription factor decoy technologies to combat pain and inflammatory conditions. Central to its efforts is the AYX platform of transcription factor decoys, which includes brivoligide, currently progressing through Phase II clinical development for reducing post-surgical discomfort. Additionally, AYX2 is a pre-clinical candidate being explored for its potential in treating localized chronic pain. Established in 2007, the company's corporate headquarters are situated in San Francisco, California.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$581.00
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Adynxx, Inc. (ADYX)

Category

Stock price history for Adynxx, Inc. (ADYX)
Highest end of day price: $0.00 on 2026-08-01

Lowest end of day price: $176.75 on 1998-12-01
Stock price history of Adynxx, Inc. from 1998 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 0.00%
2025 5.44%
2024 -9.43%
2023 -16.00%
2022 -98.67%
2021 -95.38%
2020 -82.63%
2019 -91.35%
2018 7.40%
2017 -67.79%
2016 -71.93%
2015 -48.93%
2014 -38.71%
2013 222.40%
2012 -31.95%
2011 -49.51%
2010 -10.76%
2009 1.67%
2008 -66.17%
2007 -18.69%
2006 -63.01%
2005 -60.31%
2004 29.59%
2003 2,783.48%
2002 52.14%
2001 29.87%
2000 -64.49%
1999 125.40%
1998 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$527.87 36.13%
US
$873.57 37.02%
NL
$736.38 8.73%
CH
$263.09 20.45%
BE
$1.07K -5.56%
KR